A recent study found that GLP-1 medications like Ozempic and Wegovy may help improve breast cancer survival rates among women ...

A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...

An experimental drug from Revolution Medicines that nearly ​doubled survival time for patients with advanced pancreas cancer ...

​Daraxonrasib is a once-daily oral pill that demonstrated statistically significant and clinically meaningful improvements in ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

Gallbladder cancer (GBC) is an extremely aggressive biliary tract malignancy characterized by silent early progression, ...

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

Colon cancer patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind international experiment. The research, presented at the American Society of ...

The American Cancer Society's annual cancer statistics report reveals that for the first time, 70% of people diagnosed with cancer in the U.S. survive past five years, marking a significant milestone ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.